Shares of Phibro Animal Health Corp (NASDAQ:PAHC) have been given an average recommendation of “Hold” by the seven brokerages that are currently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $38.20.
A number of research firms recently issued reports on PAHC. Zacks Investment Research downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a report on Wednesday, February 7th. BidaskClub downgraded shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Friday, January 26th. Credit Suisse Group boosted their target price on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a report on Tuesday, February 6th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $42.00 target price on shares of Phibro Animal Health in a report on Friday, November 10th.
Phibro Animal Health (NASDAQ PAHC) traded up $0.40 during trading on Wednesday, reaching $38.75. 173,555 shares of the company were exchanged, compared to its average volume of 89,833. Phibro Animal Health has a 52-week low of $26.70 and a 52-week high of $40.25. The stock has a market capitalization of $1,560.00, a P/E ratio of 22.66, a price-to-earnings-growth ratio of 2.72 and a beta of 1.18. The company has a current ratio of 3.12, a quick ratio of 1.75 and a debt-to-equity ratio of 1.82.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be paid a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, March 6th. This represents a $0.40 annualized dividend and a yield of 1.03%. Phibro Animal Health’s dividend payout ratio is currently 23.39%.
In other Phibro Animal Health news, COO Larry Lee Miller sold 54,572 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $35.36, for a total transaction of $1,929,665.92. Following the completion of the sale, the chief operating officer now directly owns 8,582 shares in the company, valued at $303,459.52. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Dean J. Warras sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $35.62, for a total transaction of $356,200.00. Following the sale, the insider now owns 10,000 shares of the company’s stock, valued at $356,200. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,754 shares of company stock valued at $2,789,185. 51.88% of the stock is owned by insiders.
Several hedge funds have recently made changes to their positions in PAHC. First Manhattan Co. purchased a new position in shares of Phibro Animal Health in the fourth quarter valued at $100,000. Dean Capital Investments Management LLC purchased a new position in shares of Phibro Animal Health in the fourth quarter valued at $200,000. Teacher Retirement System of Texas purchased a new position in shares of Phibro Animal Health in the fourth quarter valued at $224,000. Crossmark Global Holdings Inc. purchased a new position in shares of Phibro Animal Health in the fourth quarter valued at $253,000. Finally, Municipal Employees Retirement System of Michigan boosted its stake in shares of Phibro Animal Health by 65.9% in the third quarter. Municipal Employees Retirement System of Michigan now owns 7,250 shares of the company’s stock valued at $269,000 after purchasing an additional 2,880 shares during the period. Institutional investors and hedge funds own 47.38% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3224298/phibro-animal-health-corp-pahc-receives-average-rating-of-hold-from-analysts.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.